Montelukast sodium hydrate

• 产品号: SML0101
• 分子式: C35H37ClNNaO4S
• 分子量: 626.18035
• 纯 度: ≥98% (HPLC)
• 保 存: desiccated

产品别名

• 标题: Montelukast sodium hydrate
• IUPAC标准名: sodium 2-[1-({[(1R)-1-{3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]acetate hydrate
• IUPAC传统名: sodium 2-[1-({[(1R)-1-{3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]acetate hydrate
• 别名: 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt hydrate

产品登记号

• MDL号: MFCD20527317

产品性质

• Empirical Formula (Hill Notation): C35H35ClNO3S·Na · xH2O
• 纯度: ≥98% (HPLC)
• 外观: white to tan powder
• 比旋光度: [α]/D +90 to +106° in methanol (c=1)
• 溶解度: DMSO: ≥8 mg/mL at 60 °C
• 保存条件: desiccated
• 保存温度: 2-8°C

产品详细信息

详细说明 (简体中文)

Biochem/physiol Actions
Montelukast sodium hydrate is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is a subtype specific CysLT1 receptor antagonist.